131 related articles for article (PubMed ID: 12142746)
1. Diagnostic significance of high mobility group I(Y) protein expression in intraductal papillary mucinous tumors of the pancreas.
Abe N; Watanabe T; Izumisato Y; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Fujioka Y; Atomi Y
Pancreas; 2002 Aug; 25(2):198-204. PubMed ID: 12142746
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.
Abe N; Watanabe T; Masaki T; Mori T; Sugiyama M; Uchimura H; Fujioka Y; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 2000 Jun; 60(12):3117-22. PubMed ID: 10866296
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.
Okada T; Masuda N; Fukai Y; Shimura T; Nishida Y; Hosouchi Y; Kashiwabara K; Nakajima T; Kuwano H
Anticancer Res; 2006; 26(4B):3105-10. PubMed ID: 16886641
[TBL] [Abstract][Full Text] [Related]
4. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
Lüttges J; Zamboni G; Longnecker D; Klöppel G
Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
7. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
[TBL] [Abstract][Full Text] [Related]
8. Expression of integrins in intraductal papillary-mucinous tumors of the pancreas as an indicator of malignancy.
Sawai H; Okada Y; Tanaka M; Funahashi H; Hayakawa T; Manabe T
Pancreas; 2004 Jan; 28(1):20-4. PubMed ID: 14707725
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Sonic hedgehog in intraductal papillary mucinous tumor of the pancreas.
Jang KT; Lee KT; Lee JG; Choi SH; Heo JS; Choi DW; Ahn G
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):294-8. PubMed ID: 17721274
[TBL] [Abstract][Full Text] [Related]
10. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
[TBL] [Abstract][Full Text] [Related]
11. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
Jinfeng M; Kimura W; Sakurai F; Moriya T; Takeshita A; Hirai I
Int J Gastrointest Cancer; 2002; 32(2-3):73-81. PubMed ID: 12794243
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
14. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
[TBL] [Abstract][Full Text] [Related]
15. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
[TBL] [Abstract][Full Text] [Related]
16. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas.
Semba S; Moriya T; Kimura W; Yamakawa M
Pancreas; 2003 Apr; 26(3):250-7. PubMed ID: 12657951
[TBL] [Abstract][Full Text] [Related]
18. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
20. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]